IP Library Granted Patent US 10,368,987
Granted Patent B2
US 10,368,987 · App. 15/177,424 · Granted Aug 6, 2019

Pre-sized prosthetic chordae implantation system

Inventors: A. Marc Gillinov (Orange Village, OH); Michael K. Banbury (Rockland, DE); Jeremy Hemingway (Cincinnati, OH); Craig B. Berky (Milford, OH); Jonathan Bauer (Cincinnati, OH)
Assignee: THE CLEVELAND CLINIC FOUNDATION
A61F2/2427A61F2/2457A61F2/2466A61B17/0643
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,368,987
App. No.
15/177,424
Granted
Aug 6, 2019
Kind
B2
Abstract

One aspect of the present disclosure includes a system comprising prosthetic chordae, at least one attachment member including a channel, a female securing member, and a papillary penetration member configured to pass through the channel, the chordae, and the securing member when implanted in a patient's heart. The penetration member includes an axis.

Claims (26)

1. A system comprising:

first and second prosthetic chordae loops;

a first pledget;

a second pledget; and

a papillary penetration member, wherein a portion of the penetration member is configured to pass through the first pledget, the first and second chordae loops, and the second pledget when the penetration member is implanted in a patient's heart;

wherein the portion of the penetration member includes a long axis;

wherein the penetration member includes a proximal end and a sharpened distal tip;

wherein the penetration member includes a needle, the needle including the sharpened distal tip;

wherein the penetration member directly contacts each of the first and second chordae loops;

wherein the first chordae loop directly contacts the first pledget;

wherein portions of each of the first and second chordae loops are configured to be between an additional portion of the penetration member and the first pledget when the penetration member is implanted in the patient's heart;

wherein the first chordae loop has a first circumference and the second chordae loop has a second circumference substantially equal to the first circumference;

wherein the first chordae loop consists of a single monolithic first suture tied into a first knot and the second chordae loop consists of a single monolithic second suture tied into a second knot that is separate from the first knot;

wherein the first pledget includes polytetrafluoroethylene, the second pledget includes polytetrafluoroethylene, the first suture includes polytetrafluoroethylene, and the second suture includes polytetrafluoroethylene.

2. The system of claim 1 , wherein each of the first and second chordae loops includes a plurality of short arms which respectively extend across the first and second chordae loops.

3. The system of claim 1 comprising a deployment apparatus comprising first and second jaws spaced from one another to accommodate a width of papillary muscle and deploy the penetration member through the papillary muscle.

4. The system of claim 3 , wherein the penetration member is configured to pass from the first jaw and into the second jaw.

5. The system of claim 1 comprising a third pledget.

6. The system of claim 5 , wherein portions of each of the first and second chordae loops are configured to be between the first and third pledgets when the penetration member is implanted in the patient's heart.

7. The system of claim 1 wherein each of the first and second sutures comprises expanded polytetrafluoroethylene (ePTFE).

8. The system of claim 1 wherein:

when fully extended the first chordae loop substantially lies within a first plane and when fully extended the second chordae loop substantially lies within a second plane;

the long axis is configured to be non-coplanar with at least one of the first or second planes when the penetration member is implanted in the patient's heart.

9. The system of claim 1 wherein:

when fully extended the first chordae loop substantially lies within a first plane and when fully extended the second chordae loop substantially lies within a second plane;

the long axis is configured to be substantially orthogonal with at least one of the first or second planes when the penetration member is implanted in the patient's heart.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
SECURITY INTEREST Recorded Jan 18, 2024
From: ON-X LIFE TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 066160/0237 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
Continuity (4)
Continuation 13890308 · May 9, 2013
Continuation 12750800 · Mar 31, 2010
Provisional Application 61164937 · Mar 31, 2009
Related Publication 20160278919A1 · Sep 29, 2016